Trending News
NASDAQ: HCWB 399.9%
HCW Biologics Announces Positive Results for Preliminary Human Data Readout for Phase 1 Clinical Trial Evaluating IL-2 Based Fusion Immunotherapeutic, HCW9302 Monotherapy, in Alopecia Areata
NASDAQ: AVAV 21.1%
AVAV Price Target Alert: $220.00. Issued by Stifel Nicolaus
NASDAQ: SDOT 19.99%
Insider Signals and Potential Moonshots that Could Reset Valuations
NASDAQ: BTCT 33.71%
Expected US Company Earnings on Wednesday, October 1st, 2025
NASDAQ: AIRJ 18.82%
Why Did AirJoule Technologies Stock Give Back Most of Its Gain This Week?
NASDAQ: SILC 15.3%
Silicom to Participate in 21st Annual Needham Technology, Media, & Consumer Conference
NASDAQ: HCWB 21.1%
NASDAQ: SDOT 21.1%
NASDAQ: BTCT 21.1%
NASDAQ: AIRJ 21.1%
